Cargando…
Supplementary Pharmacotherapy for the Behavioral Abnormalities Caused by Stressors in Humans, Focused on Post-Traumatic Stress Disorder (PTSD)
Used as a supplement to psychotherapy, pharmacotherapy that addresses all of the known metabolic and genetic contributions to the pathogenesis of psychiatric conditions caused by stressors would require an inordinate number of drugs. Far simpler is to address the abnormalities caused by those metabo...
Autor principal: | Fessel, Jeffrey |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9967886/ https://www.ncbi.nlm.nih.gov/pubmed/36836215 http://dx.doi.org/10.3390/jcm12041680 |
Ejemplares similares
-
Formulating treatment of major psychiatric disorders: algorithm targets the dominantly affected brain cell-types
por: Fessel, Jeffrey
Publicado: (2023) -
Suicidality in post-traumatic stress disorder (PTSD) and complex PTSD (CPTSD)
por: Longo, L., et al.
Publicado: (2021) -
Current Knowledge and Attitudes Concerning Cost-Effectiveness in Glaucoma Pharmacotherapy: A Glaucoma Specialists Focus Group Study
por: Feldman, Robert M, et al.
Publicado: (2020) -
Lifetime traumatic stressors and adverse childhood experiences uniquely predict concurrent PTSD, complex PTSD, and dissociative subtype of PTSD symptoms whereas recent adult non-traumatic stressors do not: results from an online survey study
por: Frewen, Paul, et al.
Publicado: (2019) -
Pharmacotherapy of post-traumatic stress disorder: going beyond the guidelines
por: Davidson, Jonathan
Publicado: (2016)